Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML) Article

Full Text via DOI: 10.1182/blood-2018-99-115018 Web of Science: 000454837600084
International Collaboration

Cited authors

  • Zeidner, Joshua F.; Lin, Tara L.; Vigil, Carlos E.; Dalovisio, Andrew; Wang, Eunice S.; Levy, Moshe Yair; Frattini, Mark G.; Lee, Daniel J.; Montesinos, Pau; Burgues, Juan Miguel Miguel Bergua; Schriber, Jeffrey R.; Anthony, Stephen; Bearss, David J.; Smith, B. Douglas

Publication date

  • 2018

Published in

International Standard Serial Number (ISSN)

  • 0006-4971


  • 132